Financhill
Back

Monte Rosa Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Monte Rosa Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 15.78 Buy
20-day SMA: 14.51 Buy
50-day SMA: 11.59 Buy
200-day SMA: 6.67 Buy
8-day EMA: 15.7 Buy
20-day EMA: 14.53 Buy
50-day EMA: 12.07 Buy
200-day EMA: 7.95 Buy

Monte Rosa Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 71.78 Buy
Chaikin Money Flow: 1124766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.7 - 15.5) Buy
Bollinger Bands (100): (4.51 - 12.25) Buy

Monte Rosa Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Monte Rosa Therapeutics, Inc. Stock

Is Monte Rosa Therapeutics, Inc. Stock a Buy?

GLUE Technical Analysis vs Fundamental Analysis

Buy
69
Monte Rosa Therapeutics, Inc. (GLUE) is a Buy

Is Monte Rosa Therapeutics, Inc. a Buy or a Sell?

Monte Rosa Therapeutics, Inc. Stock Info

Market Cap:
1.1B
Price in USD:
16.86
Share Volume:
1.3M

Monte Rosa Therapeutics, Inc. 52-Week Range

52-Week High:
16.99
52-Week Low:
3.50
Buy
69
Monte Rosa Therapeutics, Inc. (GLUE) is a Buy

Monte Rosa Therapeutics, Inc. Share Price Forecast

Is Monte Rosa Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Monte Rosa Therapeutics, Inc.

Is Monte Rosa Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $1.17 per share.

Technical Analysis of Monte Rosa Therapeutics, Inc.

Should I short Monte Rosa Therapeutics, Inc. stock?

* Monte Rosa Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.